88
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Alginate encapsulation for bupivacaine delivery and mesenchymal stromal cell immunomodulatory cotherapy

, , , , , , , , & show all
Pages 87-97 | Published online: 12 Mar 2019

References

  • NeteaMGBalkwillFChoncholM A guiding map for inflammation Nat Immunol 2017 18 8 826 831 28722720
  • MorettoMMWeissLMClCIaKCombeCLKhanIA IFN-gamma-producing dendritic cells are important for priming of gut intraepithelial lymphocyte response against intracellular parasitic infection J immunol (Baltimore, Md. 1950) 2007 179 4 2485 2492
  • LirkPPicardiSHollmannMWAnaestheticsL Local anaesthetics Eur J Anaesthesiol 2014 31 11 575 585 25192265
  • BallieulRJJacobsTFHerregodsSvan Sint JanP The peri-operative use of intra-articular local anesthetics: a review Acta Anaesthesiol Belg 2009 60 2 7 19459550
  • BeckerDEReedKL Local anesthetics: review of pharmacological considerations Anesth Progr 2012 59 2 90 102
  • GouinJPKiecolt-GlaserJK The impact of psychological stress on wound healing: methods and mechanisms Immunol Allergy Clin North Am 2011 31 1 81 93 21094925
  • GarimellaVCelliniCControlPP Postoperative pain control Clin Colon Rectal Surg 2013 26 3 191 196 24436674
  • VyasKSRajendranSMorrisonSD Systematic review of liposomal bupivacaine (Exparel) for postoperative analgesia Plast Reconstr Surg 2016 138 4 748e 756e
  • DregallaRCLyonsNFReischlingPDCentenoCJ Amide-type local anesthetics and human mesenchymal stem cells: clinical implications for stem cell therapy Stem Cells Transl Med 2014 3 3 365 374 24436443
  • BreuAEcklSZinkWKujatRAngeleP Cytotoxicity of local anesthetics on human mesenchymal stem cells in Local Anesthetics on Human Mesenchymal Stem Cells in Vitro Arthroscopy 2013 29 10 1676 1684 23993145
  • BourneEWrightCRoyseC A review of local anesthetic cardiotoxicity and treatment with lipid emulsion Local Reg Anesth 2010 3 11 19 22915863
  • RyuHYKimJYLimHK Bupivacaine induced cardiac toxicity mimicking an acute non-ST segment elevation myocardial infarction Yonsei Med J 2007 48 2 331 336 17461537
  • MetterleinTHoffmannPSpäthRGruberMGrafBMZinkW In vitro myotoxic effects of bupivacaine on rhabdomyosarcoma cells, immortalized and primary muscle cells Cancer Cell Int 2015 15 1 75 26225122
  • TrounsonAMcDonaldC Stem cell therapies in clinical trials: progress and challenges Cell Stem Cell 2015 17 1 11 22 26140604
  • RahnamaRWangMDangACKimHTKuoAC Cytotoxicity of local anesthetics on human mesenchymal stem cells J Bone Joint Surg Am 2013 95 2 132 137 23324960
  • LucchinettiEAwadAERahmanM Antiproliferative effects of local anesthetics on mesenchymal stem cells: potential implications for tumor spreading and wound healing Anesthesiology 2012 116 4 841 856 22343474
  • BarminkoJKimJHOtsukaS Encapsulated mesenchymal stromal cells for in vivo transplantation Biotechnol Bioeng 2011 108 11 2747 2758 21656712
  • PittengerMFMackayAMBeckSC Multilineage potential of adult human mesenchymal stem cells Science 1999 284 5411 143 147 10102814
  • MeirellesLSFontesAMCovasDTCaplanAI Mechanisms involved in the therapeutic properties of mesenchymal stem cells Cytokine Growth Factor Rev 2009 20 5–6 419 427 19926330
  • SakaguchiYSekiyaIYagishitaKMunetaT Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source Arthritis Rheum 2005 52 8 2521 2529 16052568
  • HegyiBSágiBKovácsJ Identical, similar or different? learning about immunomodulatory function of mesenchymal stem cells isolated from various mouse tissues: bone marrow, spleen, thymus and aorta wall Int Immunol 2010 22 7 551 559 20497958
  • GrayAMaguireTSchlossRYarmushML Identification of IL-1β and LPS as optimal activators of monolayer and alginate-encapsulated mesenchymal stromal cell immunomodulation using design of experiments and statistical methods Biotechnol Prog 2015 31 4 1058 1070 25958832
  • BarminkoJANativNISchlossRYarmushML Fractional factorial design to investigate stromal cell regulation of macrophage plasticity Biotechnol Bioeng 2014 111 11 2239 2251 24891120
  • GrayAMarrero-BerriosIWeinbergJ The effect of local anesthetic on pro-inflammatory macrophage modulation by mesenchymal stromal cells Int Immunopharmacol 2016 33 48 54 26854576
  • GrayAMarrero-BerriosIGhodbaneM Effect of local anesthetics on human mesenchymal stromal cell secretion Nano Life 2015 5 2 1550001 1550014 26539251
  • OhriRWangJCBlaskovichPD Inhibition by local bupivacaine-releasing microspheres of acute postoperative pain from hairy skin incision Anesth Analg 2013 117 3 717 730 23921651
  • SantamariaCMWoodruffAYangRKohaneDS Drug delivery systems for prolonged duration local anesthesia Mater Today 2017 20 1 22 31
  • ShikanovADombAJWeinigerCF Long acting local anesthetic–polymer formulation to prolong the effect of analgesia J Contr Release 2007 117 1 97 103
  • Sokolsky-PapkovMGolovanevskiLDombAJWeinigerCF Prolonged local anesthetic action through slow release from poly(lactic acid co castor oil) Pharmaceut Res 2009 26 1 32 39
  • JiaXColomboGPaderaRLangerRKohaneDS Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid Biomaterials 2004 25 19 4797 4804 15120526
  • KimTSeolDRHahmS-C Analgesic effect of intra-articular injection of temperature-responsive hydrogel containing bupivacaine on osteoarthritic pain in rats Bio Med Res Int 2015 2015 9 1 9
  • CohenS Extended pain relief trial utilizing infiltration of Exparel®, a long-acting multivesicular liposome formulation of bupivacaine: a phase IV health economic trial in adult patients undergoing open colectomy J Pain Res 2012 5 567 572 23204866
  • LewisAN Liposoman Bupivacaine (Exparel) 2013 Available from: https://www.pharmacytimes.com/publications/health-system-edition/2013/january2013/liposomal-bupivacaine-exparel Accessed December 5, 2017
  • ButzDRShenaqDSRundellVL Postoperative pain and length of stay lowered by use of Exparel in immediate, implant-based breast reconstruction Plast Reconstr Surg Glob Open 2015 3 5 e391 26090281
  • BramlettKOnelEViscusiERJonesK A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty Knee 2012 19 5 530 536 22285545
  • MontMABeaverWBDysartSHBarringtonJWdel GaizoDJ Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trial J Arthroplasty 2018 33 1 90 96 28802777
  • DastaJRamamoorthySPatouGSinatraR Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting Curr Med Res Opin 2012 28 10 1609 1615 22900785
  • GorfineSROnelEPatouGKrivokapicZV Bupivacaine extended release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial Dis Colon Rectum 2011 54 12 1552 1559 22067185
  • MaguireTDavisMMarrero-BerriosI Control release anesthetics to enable an integrated anesthetic: mesenchymal stromal cell therapeutic Int J Anesthesiol Pain Med 2016 2 1 3 31106286
  • DavisMSMarrero-BerriosIPerezXI Alginate-liposomal construct for bupivacaine delivery and MSC function regulation Drug Deliv Transl Res 2018 8 1 226 238 29204926
  • AguadoBAMulyasasmitaWSuJLampeKJHeilshornSC Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers Tissue Eng Part A 2012 18 7–8 806 815 22011213
  • FDA Bupivacaine hydrochloride injection, USP 2012 Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018692s015lbl.pdf
  • BrounéusFKaramiKBeroniusPSundelöfL Diffusive transport properties of some local anesthetics applicable for iontophoretic formulation of the drugs Int J Pharm 2001 218 1–2 57 62 11337149
  • LiRHAltreuterDHGentileFT Transport characterization of hydro-gel matrices for cell encapsulation Biotechnol Bioeng 1996 50 4 365 373 18626985
  • SargentAMillerRH MSC therapeutics in chronic inflammation Curr Stem Cell Rep 2016 2 2 168 173 28133600
  • ShinTHKimHSChoiSKangKS Mesenchymal stem cell therapy for inflammatory skin diseases: clinical potential and mode of action Int J Mol Sci 2017 18 2 244
  • GerdoniEGalloBCasazzaS Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis Ann Neurol 2007 61 3 219 227 17387730
  • GrayASchlossRSYarmushM Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells Technology 2016 4 3 201 215 29732384